Background: Cardiac death is increased in peritoneal dialysis (PD) patients. Pulse wave velocity (PWV) is a measurement of arterial stiffness, and previous reports linked PWV to increased extracellular water (ECW). As cyclers and icodextrin are increasingly used, we wished to determine whether this association between PWV and ECW remains. Methods: We measured aortic PWV (aPWV) and bioimpedance (InBody, Seoul, South Korea) in consecutive PD patients attending for peritoneal membrane testing. Results: 189 patients were included, 62.4% male, mean age 63.1 ± 15.2 years, 45.3% diabetic, median dialysis duration 12.3 (6.5-25.1) months, 71.4% using cyclers, weight 73.0 ± 16.1 kg, systolic blood pressure 142 ± 21 mm Hg, aPWV 10.4 ± 5.1 m/s. aPWV was associated with pulse pressure (r = 0.26, p = 0.001), Davies comorbidity score (r = 0.18, p = 0.013), and N-terminal pro-brain-type natriuretic peptide (NTproBNP; r = 0.18, p = 0.011). Patients with aPWV ≥10 m/s were older (65.9 ± 13.6 vs. 60.1 ± 16.3 years, p < 0.01) with a higher ECW-to-total body water ratio (0.400 ± 0.012 vs. 0.396 ± 0.013, p < 0.05), but ECW/height was not different (8.52 ± 2.32 vs. 8.75 ± 1.78 L/m), as was NTproBNP (2,472 [788-5,422] vs. 1,234 [410-6,230] ng/L). On multivariable testing, aPWV was positively associated with β-blocker prescription (standardised β coefficient [Stβ] 0.3, 95% confidence limits [95% CL] 0.7-2.6, p = 0.001) and negatively with icodextrin prescription (Stβ 0.19, 95% CL -0.2 to -2.1, p = 0.04). Conclusions: Compared to previous studies, we did not find an independent association between aPWV and ECW and estimates of ECW excess, using the InBody bioimpedance device, suggesting that vascular stiffness in PD patients is more complex than simple ECW volume expansion in PD patients.
Background
Although there has been some improvement in the survival of dialysis patients in recent times, mortality remains high, compared to the general population, with 5-year survival rates similar to or worse than those of some of the more common solid organ malignancies [1] . Cardiovascular causes continue to be the major contributor of this excess mortality. Whereas atheromatous coronary artery disease with cholesterol-rich plaque formation is the predominant cardiovascular risk factor for the general population, dialysis patients typically develop arteriosclerosis leading to increased risk of heart failure, stroke and cardiac arrhythmias [2] .
Arterial stiffness is one of the first clinically detectable indicators of arteriosclerosis. Pulse wave velocity (PWV) is the most validated non-invasive method of determining arterial stiffness, and as such is considered the gold standard measurement [3, 4] . Aortic stiffness is recognised as an important independent risk factor for cardiovascular mortality in the general population and also for dialysis patients [5] . Previous studies of PWV measurements in peritoneal dialysis (PD) patients have varied in their observations, with some suggesting an association with both lower serum albumin and residual renal function and higher C-reactive protein (CRP) [6] [7] [8] , whereas others have reported associations with extracellular water (ECW) overhydration [9] [10] [11] . Due to these differences in the reported literature, and changes in patient demographics and PD prescriptions over time, we decided to prospectively measure PWV in a cohort of PD patients, to determine whether patients with an increased ECW had higher PWV.
Patients and Methods
The electronic health care records of 189 adult patients with chronic kidney disease stage 5, who had been treated with PD and had PWV measurements taken when attending for peritoneal membrane assessment, were reviewed. Peritoneal transport was calculated as the 4-h peritoneal dialysate effluent creatinine-to-serum ratio (peritoneal equilibrium test), weekly urea clearance (Kt/V urea ) and dietary normalised protein nitrogen appearance (nPNA) calculated by standard methods from 24-h urine and peritoneal dialysate effluent samples [12] . No patient had been treated for PD peritonitis or had an acute hospital admission within the preceding 3 months. All patients had been on PD for a minimum of 2 months.
We used an 8-electrode multi-frequency segmental bioimpedance device (InBody 720, Seoul, South Korea) following a standardised protocol, making measurements after patients had passed urine and the peritoneal dialysate had been drained out [13, 14] . Measurements were made on the same day as the peritoneal equilibrium test and aortic PWV (aPWV). We measured total body water (TBW), ECW, intracellular water (ICW) and body composition in the standing position. The bioimpedance device was regularly serviced and calibrated. We made estimates of increased ECW as the ratio of ECW/TBW, ECW/height and ECW/ICW and body weight [15] . Blood tests were taken concurrently and analysed by standard methods (Roche Integra, Roche diagnostics, Lewes, UK) for urea, creatinine, albumin, haemoglobin, CRP, haemoglobin A 1c (HbA 1c ) and N-terminal pro-brain-type natriuretic peptide (NTproBNP) [16, 17] . Patient comorbidity was assessed using the Davies comorbidity scoring system [18] .
Aortic-brachial PWV was measured using the Tensio Clinic Ateriograph (TensioMed Kft., Budapest, Hungary) which has been validated against direct invasive measurements [19] and has also been shown to be the most reproducible of the currently available devices for measuring PWV [20] . In keeping with standard practice, aPWV measurements were corrected for heart rate. PWV measurements were not able to be recorded in patients with atrial fibrillation, other arrhythmias, and patients with no recordable upper arm blood pressure recordings. We used the European Society of Hypertension consensus of a PWV of > 10 m/s to reflect abnormal PWV [21] .
Patients underwent clinical examination at the time of PWV and were graded by the same clinical observer according to whether the jugular venous pulse was elevated and peripheral oedema graded on a 4-point scale (0: no oedema on finger compression over the lower tibia, 1: minimal oedema -minor indentation but no visible pitting, 2: some oedema -visible pitting after compression, 3: moderate oedema -oedema visible on inspection and pitting greater than grade 2).
Two-dimensional echocardiograms were performed (Philips IE33, Philips Medical Systems, Eindhoven, the Netherlands) in a subset of 169 (89.4%) patients. Diastolic dysfunction was graded in keeping with the American Society of Echocardiography guidelines [22, 23] .
Statistical Analysis
Data were checked for normality using the D'Agostino and Pearson normality test, and results were expressed as mean ± standard deviation, median and interquartile range, or percentage. The Student t, Mann-Whitney U and χ 2 tests, with corrections where appropriate, were used to compare groups, and non-parametric data were log transformed if required for further analysis. Factors individually associated with aPWV were determined using a multivariable regression model, using variables which correlated with PWV (p < 0.1) by univariate analysis. The model was checked for collinearity. Statistical analysis was performed using Graph Pad Prism (version 8.0, Graph Pad, San Diego, CA, USA) and SPSS (version 24, IBM, Armonk, New York, NY, USA). Statistical significance was taken at or below the 5% level.
Results
aPWV was measured in 189 patients by the same observer; 118 (62.4%) were male, mean age was 63.1 ± 15.2 years, 86 (45.3%) were diabetic, with median dialysis vintage of 12.3 (6.5-25.1) months. Their mean weight was 73.0 ± 16.1 kg, systolic blood pressure was 142 ± 21 mm Hg, diastolic blood pressure was 81 ±14 mm Hg, PWV was 10.5 ± 4.1 m/s and heart rate-adjusted PWV was 10.4 ± 5.1 m/s. Only 1 patient had an elevated jugular venous pulse, 55% of the patients had no lower limb oedema, 33.9% had minimal oedema, 10.6% had some oedema, and 1.1% observable oedema.
We divided the patients into those with a lower aPWV of ≤10 and a higher aPWV of > 10 cm/s [21] (Table 1) . Patients with greater aPWV were older and fewer used icodextrin dialysates. More patients with higher aPWV were prescribed beta-blockers, but fewer were prescribed angiotensin-converting enzyme inhibitors and angiotensin receptor blockers (ARBs). However, mean arterial blood pressure did not differ between the groups (Table 1 ). There was no difference in body composition between the groups apart from visceral fat ( Table 2 ), but those patients with higher aPWV had an increased ECW/TBW ratio and lower serum urea concentrations. On echocardiography, left ventricular mass and left ventricular mass adjusted for body size [23] were not different ( Table 3 ). Excluding measurements associated with vascular stiffness, echocardiographic assessments of the peak aortic valve gradient and left ventricular diastolic dysfunction were greater for those with higher aPWV. NTproBNP concentrations were not different between the groups. Although there were no significant differences in the clinical examination of patients with regard to signs of fluid excess, patients with greater aPWV had higher New York Heart Association (NYHA) grades of heart failure.
On univariate analysis, PWV was associated with pulse pressure (r = 0.26, p = 0.001), Davies comorbidity score (r = 0.18, p = 0.013), NTproBNP (r = 0.18, p = 0.011), and negatively with nPNA (r = -1.07, p = 0.024). A number of other variables had weaker positive associations, 0.05 < p < 0.1, including age, ECW/TBW, glycated haemoglobin, urea, litres of dialysate used/day, ECW overhydration, left ventricular ejection fraction, and ferritin. A multivariable regression model showed that aPWV was associated with greater prescription of beta-blockers, but less usage of icodextrin dialysates and lower log CRP values (Table 4 ). Adjusted for age, gender, use of 22.7% dextrose, icodextrin, serum urea, albumin, C-reactive protein (CRP), N-terminal brain natriuretic peptide, ferritin, Davies comorbidity score, New York Heart Association grade (NYHA), prescription of beta-blockers (BB), angiotensin-converting enzyme inhibitors or angiotensinconverting enzyme inhibitors, statins, smoking status, left ventricular mass index, glycosylated haemoglobin, percentage body fat. If appropriate non-parametric variables were log converted. Standard error of β (StEβ), standardised β (Stβ), 95% confidence limits (95% CL). R 2 = 0.22. Discussion PWV is currently considered the "gold" standard for the non-invasive measurement of arterial stiffness, due to the reliability of measurements [3, 4] . We measured aPWV, as this is more reproducible compared to carotid-femoral measurements, which combine both central and conduit arteries [19, 24] .
In the general population, PWV increases with age [25] , and those in our cohort with an aPWV > 10 m/s were older. Previous studies in PD patients have reported a variable effect of age, with some studies reporting an association [26, 27] and others no association [10, 11] . As expected, there was an association between aPWV and pulse pressure, and more patients with a higher aPWV had diastolic dysfunction on echocardiography. Several studies have reported an association between PWV and increased ECW overhydration [9, 10] . There has been a debate as to the relative importance of ECW volume expansion and hypertension in dialysis patients, since, although the majority of patients with ECW expansion have hypertension, volume status does not explain all cases [28, 29] . Although our patients with a higher aPWV had a greater ECW/ TBW ratio, there was no difference when adjusting ECW for height, or when calculating overhydration based on the difference between measured ECW and that expected based on measured ICW [15] . Whereas most previous studies in PD patients have used various bioimpedance machines (Xitron technology, San Diego, CA, USA) [16] , and bioimpedance measurements have been made in the supine position with peritoneal dialysate in situ, we used a different device for measurements made with the peritoneal dialysate drained out and in the standing position. Bioimpedance machines use different algorithms, and as such may not be directly comparable. We have previously studied both devices [30] . Bioimpedance measurements can be affected by the presence of intra-abdominal fluid [31] , and if not, enough time has been allowed for fluid to equilibrate on taking the supine position [32] . We have previously demonstrated an association between NTproBNP and increased ECW in PD patients [33] , and in this study, NTproBNP was not significantly different between the normal and high aPWV groups.
We were unable to demonstrate any significant association between aPWV and left ventricular mass. This may be due to differences in the quality and duration of pre-dialysis medical care and the introduction of clinical guideline targets for blood pressure control [34] , and other studies measuring a composite of central and conduit artery PWV [9, 10] . However, more importantly, most of these previous studies failed to report on the clinical examination of patients as to whether patients had clinical signs of ECW expansion or symptomatic heart failure [9, 10] .
As PWV is a marker of vascular stiffness, the association with prescription of beta-blocker antihypertensives is not unexpected. More patients prescribed angiotensin-converting enzyme inhibitors and ARBs had lower aPWV, and this effect was most marked with ARBs alone (χ 2 = 5.0, p = 0.025). This finding is in keeping with a previous report suggesting that ARBs, particularly when combined with HMGCoA3 reductase inhibitors (statins), are associated with lower PWV [35] .
Some studies have reported an effect of body size on PWV [11] but we did not find such an association, although there was more visceral fat in our patients with higher aPWV, which has been previously reported, and there is a recognised association between visceral adiposity and cardiovascular mortality [36] .
Our study differs from previous reports in that the majority of our patients used icodextrin compared to earlier studies [9, 10, 26, 27] , and icodextrin has been shown to improve hydration status and reduce ECW expansion compared to standard and higher glucosecontaining dialysates [37] . As such, the lower aPWV in patients prescribed icodextrin would support an association between ECW and aPWV, but in our study, only 1 patient had clinical signs of ECW overhydration with a raised jugular venous pulse and peripheral oedema.
Previous studies have reported an association between inflammation and PWV [8, 26, 38] , and inflammatory states can lead to an increase in ECW [16, 17] . However, we noted the opposite in that patients with higher CRP values were associated with lower aPWV in our multivariable model, although equally other studies have reported no effect of inflammatory cytokines on PWV [39] . We used a single measurement of CRP taken on the day of testing and not a time-averaged measurement, and so the CRP may not have been representative, and minor changes may have affected aPWV. As with any cross-sectional study, we can only report associations rather than causality, and similarly without a longitudinal follow-up we cannot comment on survival, although in the UK PD technique and patient survival is confounded by the relatively high rates of change in modalities, both to transplantation and haemodialysis. Our study differs from previous reports due to the number of patients treated by overnight cyclers compared to continuous ambulatory PD and the high usage of icodextrin. In addition, compared to other studies, we measured aPWV and ECW in the erect position with dialysate drained out with a multifrequency device.
Compared to previous studies, we did not find an independent association between faster aPWV and ECW and between faster aPWV and estimates of ECW excess, suggesting that vascular stiffness in PD patients is more complex than simply due to ECW volume expansion alone in PD patients [40] , as we found an association with beta-blockers, despite adjusting for heart rate, and lower aPWV in patients using icodextrin, which may result in greater sodium losses [41] , and markers of inflammation, such as CRP.
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